Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acids
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0182
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acids
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.281
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0865
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.238
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HOM
|
f:156m
|
|
|
NotProcessed |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HOM
|
f:152m
|
|
|
NotProcessed |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HOM
|
f:23m
|
|
|
NotProcessed |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.106
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.285
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.000170
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.791
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00819
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.136
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0301
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.873
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.191
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.661
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0160
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0581
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0109
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0352
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.609
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.750
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0650
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0890
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0563
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.366
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.227
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.718
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.724
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
7f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.930
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.405
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.713
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.167
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.328
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.380
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.880
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HOM
|
f:156m
|
|
|
NotProcessed |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HOM
|
f:152m
|
|
|
NotProcessed |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HOM
|
f:23m
|
|
|
NotProcessed |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.354
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.421
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.234
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.266
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.455
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
7.86×10-05
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000689
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
7f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0993
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.119
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.280
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.191
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.541
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.141
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.903
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Insulin Blood Level / Insulin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.295
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Insulin Blood Level / Insulin
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.706
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
35f:35m
|
|
|
NotProcessed |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
35f:45m
|
|
|
NotProcessed |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
7f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.555
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.774
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00557
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.555
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.269
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.794
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HOM
|
f:1m
|
|
|
NotProcessed |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HOM
|
f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0439
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HOM
|
f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.811
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.141
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.550
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Carbon dioxide production
|
HOM
|
f:23m
|
|
|
NotProcessed |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Carbon dioxide production
|
HOM
|
f:152m
|
|
|
NotProcessed |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Carbon dioxide production
|
HOM
|
f:156m
|
|
|
NotProcessed |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglycerides
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0170
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglycerides
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0601
|
Successful |
Tatdn3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
1.49×10-05
|
Successful |
Tatdn3tm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0666
|
Successful |